Sarcopenia can contribute to the onset of T2D by reducing skeletal muscle mass, a major site for insulin-mediated glucose disposal, while sarcopenia is also associated with physical inactivity and frailty, both risk factors for T2D [73,74,75]. This evidence concerns the gene INS and sarcopenia.